Latest stories on RCUS
Arcus Biosciences Announces New Employment Inducement Grants
StockTitan50 · neutralgeneral
Arcus Biosciences, Inc. (RCUS) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
Seeking Alpha56 · neutralgeneral
Arcus Biosciences Nears Key Data Milestone in Pancreatic Cancer Trial
TipRanks67 · bullishproduct/pr
Arcus Biosciences price target raised to $40 from $35 at Truist
The Fly63 · neutralanalyst
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
StockTitan55 · neutralgeneral
Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firm
PR Newswire48 · neutralgeneral
Could Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)’s Cancer Drug Partnership Create a New Treatment Standard?
Yahoo Finance66 · bullishproduct/pr
Arcus Biosciences (RCUS) Q2 2026 Earnings Call Transcript
The Motley Fool58 · neutralearnings
Arcus Biosciences Announces New Employment Inducement Grants
StockTitan50 · neutralgeneral
Arcus Biosciences price target raised to $23 from $22 at Morgan Stanley
The Fly61 · neutralanalyst
Arcus Biosciences Price Target Raised To 42 From 34 At Goldman Sachs
The Fly61 · neutralanalyst
Arcus outlines $5B-$10B casdatifan opportunity as PEAK-1 targets year-end 2026 enrollment and PEAK-20 plans 2026 start
Seeking Alpha63 · neutralproduct/pr
Arcus Biosciences, Inc. (RCUS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Arcus Biosciences, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Arcus Biosciences, Inc. (RCUS) files 8-K
SEC 8-K50 · neutralgeneral
Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update
StockTitan56 · neutralearnings
Arcus Biosciences Announces New Employment Inducement Grants
StockTitan50 · neutralgeneral
Arcus Biosciences Announces New Employment Inducement Grants
Barchart50 · neutralgeneral
Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions
Seeking Alpha63 · neutralanalyst
H.C. Wainwright reiterates Arcus Biosciences stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Arcus in supply deal with AVEO Oncology for casdatifan combo in kidney cancer
Seeking Alpha56 · neutralproduct/pr
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
StockTitan50 · neutralgeneral
H.C. Wainwright raises Arcus Biosciences stock price target to $45
Investing.com Analyst Ratings61 · neutralanalyst